Health ❯ Healthcare ❯ Regulatory Agencies

Anvisa

Drug Monitoring Product Prohibition Drug Approval Drug Regulations Drug Prohibition Pharmacovigilance Drug Approval Process Drug Safety Suspension of Products Medication Regulations

Anvisa Logs 65 Suspected Deaths Linked to GLP-1 Weight-Loss Injections in Brazil

The regulator says the reports are safety signals rather than proven causes, leaving the approved risk–benefit profile unchanged.

Anvisa Issues Safety Alert on GLP‑1 Injection Pens After Six Suspected Pancreatitis Deaths in Brazil

Brazil Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

Anvisa Orders Lot-Specific Recalls Over Packaging Mix-Ups, Seizes Falsified Drug Batches

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

Anvisa Orders Recall of Hypofarma Furosemide Batch Over Glass-Like Material